TOKYO, Mar 11, 2021 - (JCN Newswire via SEAPRWire.com) - Fujitsu Limited and a Kyoto University research group led by Professor Yasushi Okuno of the Kyoto University Graduate School of Medicine, has developed an AI verification system called "MGeND Intelligence". When the genetic mutation(1) information of a patient is input into this system, its ability to cause disease is estimated by pathogenicity estimation AI using machine learning technology and the explanatory text of the basis of this finding is generated and displayed together with the estimated result by the explainable AI. This explanation offers a useful reference to doctors who are considering a treatment plan or genomic medical researchers. The system draws from the "Integrated Database of Clinical and Genomic Information program"(2), managed by the Japan Agency for Medical Research and Development , and from April 2021, Kyoto University plans to offer MGeND Intelligence to joint researchers and institutions.Fig. 1: System OverviewFig. 2: Flow chart of generation of explanatory text of finding basisIn addition to the pathogenicity estimation AI, the MGeND Intelligence verification system includes explainable AI that s...